Imatinib should be avoided in women planning to become pregnant or during pregnancy,
due to a higher risk of congenital malformations. However, it is not known whether imatinib …

Chronic myeloid leukemia is a chronic myeloproliferative disorder of hematopoietic stem
cells that occurs in 10% of cases in women of childbearing age. Treatment is mainly based …

PURPOSE The aim of the current work was to report the effect of imatinib on pregnancy in
patients with chronic myeloid leukemia (CML). METHODS Data were collected between …

Discovery of tyrosine kinase inhibitors has led to improvement in survival of chronic
myelogenous leukemia (CML) patients. Many young CML patients encounter pregnancy …

Chronic Myelogenous Leukemia in: Journal of the National Comprehensive Cancer Network
Volume 10 Issue 1 (2012) Jump to Content User Account Sign In to save searches and …

Pregnancy in a patient with chronic myeloid leukemia presents a therapeutic challenge.
Both dasatinib and nilotinib are indicated for first-line treatment as well as for treatment …

Management of pregnant patients with chronic myelogenous leukemia (CML) is challenging.
Some of the factors that need to be considered include stage of pregnancy, disease status …

The management of acute lymphoblastic leukemia (ALL) during pregnancy requires
treatment with high-dose chemotherapy that can pose risks to both the mother and fetus …

We analyzed the management and outcomes of pregnancies of patients with chronic
myeloid leukemia at a single center over fifteen years. Among the 203 CML female patients …

Dasatinib is a potent, broad-spectrum adenosine triphosphate (ATP) competitive tyrosine
kinase inhibitor (TKI), approved for the treatment of patients with chronic, accelerated, or …